Long-lasting symptoms are common 3 months after COVID-19 positive
In a study from Yale University, scientists found long-lasting symptoms are common 3 months after testing for COVID-19.
They compared new and ongoing symptoms and...
Scientists find new drug to treat fatty liver disease
In a study from Karolinska Institutet, scientists found a drug candidate for the treatment of fatty liver.
How COVID-19 can harm your gut health
Scientists found that COVID-19 can disrupt the gut’s microbes and allow harmful bacteria into the bloodstream.
Medical cannabis for chronic pain may help people reduce opioid use
In a study from New York State and CUNY, scientists found that receiving medical cannabis for thirty days or more may help patients on...
Widely used dietary supplement causes cancer risk and spread, study finds
Several studies have linked dietary supplements like nicotinamide riboside (NR), a form of vitamin B3, to benefits related to heart, metabolic and brain health.
But...
Scientists make an action plan to prevent Alzheimer’s disease
Memory loss, behavioral changes, cognitive deficits: Alzheimer's disease leads to a dramatic loss of autonomy for those affected and has a heavy impact on...
Ultra-processed foods may increase your cancer risk and death
In a study from Imperial College London and elsewhere, scientists found higher intake of ultra-processed foods may be linked to an increased risk of...
This sedative drug for surgery increases heart damage risk when used at night
Midazolam injection is used to produce sleepiness or drowsiness and relieve anxiety before surgery.
When midazolam is used before surgery, the patient will not remember some...
Obesity-related brain symptoms mimic Alzheimer’s disease
In a study from McGill University, scientists found a correlation between neurodegeneration in obese people and Alzheimer's disease (AD) patients.
This suggests that losing excess...
Newer type 2 diabetes drug reduces heart disease risk in men more than in...
In a study from Monash University, scientists found a common type 2 diabetes drug can reduce heart disease risk in men more than in...